Literature DB >> 23292069

Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis.

Karen D Corbin1, Manal F Abdelmalek, Melanie D Spencer, Kerry-Ann da Costa, Joseph A Galanko, Wei Sha, Ayako Suzuki, Cynthia D Guy, Diana M Cardona, Alfonso Torquati, Anna Mae Diehl, Steven H Zeisel.   

Abstract

Choline metabolism is important for very low-density lipoprotein secretion, making this nutritional pathway an important contributor to hepatic lipid balance. The purpose of this study was to assess whether the cumulative effects of multiple single nucleotide polymorphisms (SNPs) across genes of choline/1-carbon metabolism and functionally related pathways increase susceptibility to developing hepatic steatosis. In biopsy-characterized cases of nonalcoholic fatty liver disease and controls, we assessed 260 SNPs across 21 genes in choline/1-carbon metabolism. When SNPs were examined individually, using logistic regression, we only identified a single SNP (PNPLA3 rs738409) that was significantly associated with severity of hepatic steatosis after adjusting for confounders and multiple comparisons (P=0.02). However, when groupings of SNPs in similar metabolic pathways were defined using unsupervised hierarchical clustering, we identified groups of subjects with shared SNP signatures that were significantly correlated with steatosis burden (P=0.0002). The lowest and highest steatosis clusters could also be differentiated by ethnicity. However, unique SNP patterns defined steatosis burden irrespective of ethnicity. Our results suggest that analysis of SNP patterns in genes of choline/1-carbon metabolism may be useful for prediction of severity of steatosis in specific subsets of people, and the metabolic inefficiencies caused by these SNPs should be examined further.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292069      PMCID: PMC3606533          DOI: 10.1096/fj.12-219097

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  55 in total

1.  Polymorphisms associated with cholesterol and risk of cardiovascular events.

Authors:  Sekar Kathiresan; Olle Melander; Dragi Anevski; Candace Guiducci; Noël P Burtt; Charlotta Roos; Joel N Hirschhorn; Göran Berglund; Bo Hedblad; Leif Groop; David M Altshuler; Christopher Newton-Cheh; Marju Orho-Melander
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

2.  APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.

Authors:  Michael Miller; Jeffrey Rhyne; Hegang Chen; Valerie Beach; Richard Ericson; Kalpana Luthra; Manjari Dwivedi; Anoop Misra
Journal:  Arch Med Res       Date:  2007-03-26       Impact factor: 2.235

3.  Common genetic polymorphisms affect the human requirement for the nutrient choline.

Authors:  Kerry-Ann da Costa; Olga G Kozyreva; Jiannan Song; Joseph A Galanko; Leslie M Fischer; Steven H Zeisel
Journal:  FASEB J       Date:  2006-07       Impact factor: 5.191

4.  Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1.

Authors:  Gizem Rizki; Lorenzo Arnaboldi; Bianca Gabrielli; Jim Yan; Gene S Lee; Ray K Ng; Scott M Turner; Thomas M Badger; Robert E Pitas; Jacquelyn J Maher
Journal:  J Lipid Res       Date:  2006-07-08       Impact factor: 5.922

5.  Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.

Authors:  A Peter; K Kantartzis; F Machicao; J Machann; S Wagner; S Templin; I Königsrainer; A Königsrainer; F Schick; A Fritsche; H-U Häring; N Stefan
Journal:  Int J Obes (Lond)       Date:  2011-08-09       Impact factor: 5.095

6.  The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.

Authors:  Luca Valenti; Valerio Nobili; Ahmad Al-Serri; Raffaela Rametta; Julian B S Leathart; Marco A Zappa; Paola Dongiovanni; Anna L Fracanzani; Arianna Alterio; Giancarlo Roviaro; Ann K Daly; Silvia Fargion; Christopher P Day
Journal:  J Hepatol       Date:  2011-07-21       Impact factor: 25.083

7.  Sex and menopausal status influence human dietary requirements for the nutrient choline.

Authors:  Leslie M Fischer; Kerry Ann daCosta; Lester Kwock; Paul W Stewart; Tsui-Shan Lu; Sally P Stabler; Robert H Allen; Steven H Zeisel
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

8.  Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.

Authors:  Giovanni Musso; Roberto Gambino; Franco De Michieli; Marilena Durazzo; Gianfranco Pagano; Maurizio Cassader
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

9.  Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity.

Authors:  Eva Warensjö; Erik Ingelsson; Per Lundmark; Lars Lannfelt; Ann-Christine Syvänen; Bengt Vessby; Ulf Risérus
Journal:  Obesity (Silver Spring)       Date:  2007-07       Impact factor: 5.002

Review 10.  Epidemiology and natural history of NAFLD and NASH.

Authors:  Janus P Ong; Zobair M Younossi
Journal:  Clin Liver Dis       Date:  2007-02       Impact factor: 6.126

View more
  17 in total

1.  Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis.

Authors:  Rajesh Tota-Maharaj; Michael J Blaha; Irfan Zeb; Ronit Katz; Ron Blankstein; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir
Journal:  Mayo Clin Proc       Date:  2014-03-07       Impact factor: 7.616

2.  Plasma 1-carbon metabolites and academic achievement in 15-yr-old adolescents.

Authors:  Torbjörn K Nilsson; Anita Hurtig-Wennlöf; Michael Sjöström; Wolfgang Herrmann; Rima Obeid; Jennifer R Owen; Steven Zeisel
Journal:  FASEB J       Date:  2016-01-04       Impact factor: 5.191

3.  Identification of new genetic polymorphisms that alter the dietary requirement for choline and vary in their distribution across ethnic and racial groups.

Authors:  Kerry-Ann da Costa; Karen D Corbin; Mihai D Niculescu; Joseph A Galanko; Steven H Zeisel
Journal:  FASEB J       Date:  2014-03-26       Impact factor: 5.191

4.  Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.

Authors:  Danxia Yu; Xiao-Ou Shu; Yong-Bing Xiang; Honglan Li; Gong Yang; Yu-Tang Gao; Wei Zheng; Xianglan Zhang
Journal:  J Nutr       Date:  2014-10-15       Impact factor: 4.798

Review 5.  Choline's role in maintaining liver function: new evidence for epigenetic mechanisms.

Authors:  Mihai G Mehedint; Steven H Zeisel
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

6.  Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.

Authors:  Nicole E Rich; Stefany Oji; Arjmand R Mufti; Jeffrey D Browning; Neehar D Parikh; Mobolaji Odewole; Helen Mayo; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-09-29       Impact factor: 11.382

7.  Evidence for negative selection of gene variants that increase dependence on dietary choline in a Gambian cohort.

Authors:  Matt J Silver; Karen D Corbin; Garrett Hellenthal; Kerry-Ann da Costa; Paula Dominguez-Salas; Sophie E Moore; Jennifer Owen; Andrew M Prentice; Branwen J Hennig; Steven H Zeisel
Journal:  FASEB J       Date:  2015-04-28       Impact factor: 5.191

8.  Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.

Authors:  Kayleigh L Wood; Michael H Miller; John F Dillon
Journal:  BMJ Open Gastroenterol       Date:  2015-02-17

Review 9.  Choline in cystic fibrosis: relations to pancreas insufficiency, enterohepatic cycle, PEMT and intestinal microbiota.

Authors:  Wolfgang Bernhard
Journal:  Eur J Nutr       Date:  2020-08-14       Impact factor: 5.614

10.  Nutrition in pregnancy: the argument for including a source of choline.

Authors:  Steven H Zeisel
Journal:  Int J Womens Health       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.